Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 6, 2014, Pages 1351-1355

  Kate, Mahesh ^a   Szkotak, Artur ^a   Witt, Adam ^a   Shuaib, Ashfaq ^a   Butcher, Kenneth ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

anticoagulation; dabigatran; partial thromboplastin time; stroke; thrombin time; Thrombolysis

Indexed keywords

ALTEPLASE; DABIGATRAN; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; THROMBIN TIME; TRANSIENT ISCHEMIC ATTACK; ANALOGS AND DERIVATIVES; ATRIAL FIBRILLATION; BLOOD CLOTTING; DRUG EFFECTS; FIBRINOLYTIC THERAPY; MIDDLE AGED; PROCEDURES; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTITHROMBINS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; BLOOD COAGULATION; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84902436617     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.11.013     Document Type: Article

References (16)

1. K. Kirley, D.M. Qato, and R. Kornfield et al. National trends in oral anticoagulant use in the United States, 2007 to 2011 Circ Cardiovasc Qual Outcomes 5 2012 615 621
2. M. Ruecker, B. Matosevic, and P. Willeit et al. Subtherapeutic warfarin therapy entails an increased bleeding risk after stroke thrombolysis Neurology 79 2012 31 38
3. Y. Xian, L. Liang, and E. Smith et al. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator JAMA 307 2012 2600 2608
4. J. van Ryn, J. Stangier, and S. Haertter et al. Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127
5. M.E. Carr Jr., and D.A. Gabriel Hyperfibrinogenemia as a cause of prolonged thrombin clotting time Southern Med J 79 1986 563 570
6. P. Trouillas, and R. von Kummer Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke Stroke 37 2006 556 561
7. F. Van De Werf, M. Brueckmann, and S.J. Connolly et al. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: the randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN) Am Heart J 163 2012 931 937.e1
8. M. O'Donnell, W. Oczkowski, and J. Fang et al. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study Lancet Neurol 5 2006 749 754
9. N. Sangha, R. El Khoury, and V. Misra et al. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization J Stroke Cerebrovas Dis 21 2012 917.e5 917.e9
10. M.C. Matute, M. Guillan, and J. Garcia-Caldentey et al. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran Thromb Haemost 106 2011 178 179
11. A. De Smedt, S. De Raedt, and K. Nieboer et al. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran Cerebrovasc Dis 30 2010 533 534
12. L.C. Marrone, and A.C. Marrone Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report Cerebrovasc Dis 34 2012 246 247
13. V.H. Lee, J.J. Conners, and S. Prabhakaran Intravenous thrombolysis in a stroke patient taking dabigatran J Stroke Cerebrovas Dis 21 2012 916.e11 916.e12
14. I. Casado Naranjo, J.C. Portilla-Cuenca, and P.E. Jimenez Caballero et al. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran Cerebrovasc Dis 32 2011 614 615
15. S.J. Connolly, M.D. Ezekowitz, S. Yusuf RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
16. I. Rybinnik, M.T. Mullen, and S. Messe et al. Treatment of acute stroke in patients on dabigatran: A survey of us stroke specialists J Stroke Cerebrovas Dis 22 2013 1312 1316